Erratum: Reference intervals for insulin- Like growth factor-1 (IGF-I) from birth to senescence: Results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations (The Journal of Clinical Endocrinology & Metabolism (2014) 99:5 (1712-1721) DOI: 10.1210/jc.2013-3059);Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: Results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages 1712-1721

  Bidlingmaier, Martin ^a   Friedrich, Nele ^b   Emeny, Rebecca T ^c   Spranger, Joachim ^d   Wolthers, Ole D ^e   Roswall, Josefine ^f   Körner, Antje ^g   Obermayer Pietsch, Barbara ^h   Hübener, Christoph ^a   Dahlgren, Jovanna ^l   Frystyk, Jan ^i,j   Pfeiffer, Andreas F H ^d,k   Doering, Angela ^c   Bielohuby, Maximilian ^a   Wallaschofski, Henri ^b   Arafat, Ayman M ^d,k  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Children's Clinic Randers   (Denmark)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁱ AARHUS UNIVERSITY   (Denmark)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

^k GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^l German Institute of Human Nutrition Potsdam Rehbruecke ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIRTH; CALIBRATION; CANADA; CHEMILUMINESCENCE IMMUNOASSAY; CHILD; COHORT ANALYSIS; COMMUNITY SAMPLE; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL PATIENT; HUMAN; IMMUNOASSAY ANALYZER; INFANT; LABORATORY AUTOMATION; LIFESPAN; MALE; NEWBORN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTOCOL COMPLIANCE; PUBERTY; REFERENCE VALUE; SENESCENCE; SEX DIFFERENCE; UMBILICAL CORD BLOOD; UNITED STATES; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOASSAY; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 84899940936     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/clinem/dgaa641     Document Type: Erratum

References (41)

1. Melmed S, Colao A, Barkan A, et al. Guidelines for acromegaly management: an update. J Clin Endocrinol Metab. 2009;94:1509-1517.
2. Cohen P, Rogol AD, Deal CL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society , and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93:4210-4217.
3. Ho KK. Consensus guidelines for the diagnosis and treatment of adults withGHdeficiency II: a s tatement of theGHResearch Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007 ;157:695-700.
4. Growth Hormone Research Society, Pituitary Society Biochemical assessment and long-term monitoring in patients with acromegaly. statement from a joint consensus conference of the Growth Hormone Resea rch Society and the Pituitary Society. J Clin Endocrinol Metab 2004;89:3099-3102.
5. Endogenous Hormones and Breast Cancer Collaborative Group; Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010;11:530-542.
6. Khosravi J, Diamandi A, Mistry J, Scorilas A. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer. J Clin Endocrinol Metab. 2001;86: 694-699.
7. Stöckl D, Döring A, Peters A, et al. Age at menarche is associated with prediabetes and diabetes inwomen(aged 32-81 years) from the general population: The KORA F4 Study. Diabetologia. 2012;55: 681-688.
8. Friedrich N Thuesen B Jørgensen T et al. The association between IGF-I and insulin resistance: a general population study in Danish adult s Diabetes Care. 2012 35 768-773.
9. Rosskopf D, Schwahn C, Neumann F, et al. The growth hormone-IGF-I axis as a mediator for the association between FTO variants and body mass index: results o f the Study of Health in Pomerania. Int J Obes (Lond). 2011;35:364-372.
10. Frystyk J, Freda P, Clemmons DR. The current status of IGF-I assays-A 2009 update. Growth Horm IGF Res. 2010;20:8-18.
11. Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem. 2011;57:555-559.
12. Burns C, Rigsby P, Moore M, Rafferty B. The First International Standard For Insulin-like Growth Factor-1 (IGF-I) for immunoassay: preparation and calibration in an international collaborative study. Growth Horm IG F Res. 2009;19:457-462.
13. Brabant G, von zur Mühlen A, Wüster C, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter stud y. Horm Res. 2003;60:53-60.
14. NCCLS. Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline. 2nd ed. NCCLS Document EP5-A2. Wayne, PA: NCCLS; 2004
15. NCCLS. P rotocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. NCCLS Document EP17-A. Wayne, PA: NCCLS; 2004.
16. Adeli K. Closing the gaps in pediatric reference intervals: The CALIPER initiative. Clin Biochem. 2011;44:480-482.
17. Colantonio DA, Kyriakopoulou L, ChanMK,et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58:854-868.
18. Völzke H, Alte D, Schmidt CO, et al. Cohort profile: The study of health in Pomerania. Int J Epidemiol. 2011;40:294-307.
19. LacruzME,Emeny RT, Haefner S, et al. Relation between depressed mood, soma tic comorbidities and health service utilisation in older adults: results from the KORA-Age study. Age Ageing. 2012;41: 183-190
20. Kaplan RC, Petersen AK, Chen MH, et al. A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum Mol Genet. 2011
21. Isken F, Abraham U, Weickert MO, Keyhani-Nejad F, Arafat AM, Spranger J, Pfeiffer AF, Mohli g M. Annual change in insulin sensitivity. Horm Metab Res. 2011;43:720-722.
22. Cole TJ, Green PJ. Smoothing reference centile curves: The LMS method and penalized likelihood. Stat Med. 1992;11:1305-1319.
23. YeeTW.Quantile regression via vector generalized additive models. Stat Med. 2004;23:2295-2315.
24. Koenker R. Quantile Regression. New York, NY: Cambridge University Press; 2005.
25. Stone C, Koo CY. Additive Splines in Statistics. Washington, DC: American Statistical Association; 1985.
26. Wu Z, Bidlingmaier M, Friess SC, et al. A new nonisotopic, highly sensitive assay for the measurement of human placental growth hormone: development and clinical implications. J Clin Endocrinol Metab. 2003;88:804-811.
27. Javaid MK, G odfrey KM, Taylor P, et al. Umbilical venous IGF-I concentration, neonatal bone mass, and body composition. J Bone Miner Res. 2004;19:56-63.
28. Gohlke BC, Schreiner F, Fimmers R, Bartman n P, Woelfle J. Insulinlike growth factor-I in cord blood is predictive of catch-up growth in monozygotic twins with discordant growth. J Clin Endocrinol Metab. 2010;95:5375-5381.
29. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease Growth Horm IGF Res. 2003 13 113-170.
30. Elmlinger MW, Kühnel W, Weber MM, Ranke MB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med. 2004;42:654-664.
31. Berrigan D, Potischman N, Dodd KW, et al. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res. 2009;19:146-155.
32. Nelson AE, Howe CJ, Nguyen TV, et al. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes. J Clin Endocrinol Metab. 2006;91:4424-4432.
33. Hopkins KD, Lehmann ED, Jones RL, et al. Ethnicity affects IGFBP-3 and IGF-II in normal healthy young adult subjects. Clin Endocrinol (Oxf). 1996;45:327-331.
34. Casazza K, Higgins PB, Ferná ndez JR, Goran MI, Gower BA. Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents. J Clin Endocrinol Metab. 2008;93:4917-4923.
35. Cole TJ. TheLMSmethod for constructing normalized growth standards. Eur J Clin Nutr. 1990;44:45-60.
36. Fischer DC, Mischek A, Wolf S, et al. Paediatric refer ence values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Ann Clin Biochem. 2012;49:546-553.
37. La Marca A, Spada E, Grisendi V, et al. Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. Eur J Obstet Gynecol Reprod Biol. 2012;163:180-184.
38. Garagorri JM, Rodrí guez G, Lario-Elboj AJ, Olivares JL, Lario-Munoz A, Orden I. Reference levels for 17-hydroxyprogesterone, 11-desoxycortisol, cortisol, testosterone, dehydroepiandrosterone sulfate and androstenedione in infants from birth to six months of age. Eur J Pediatr. 2008;167:647-653.
39. Kong AP, Wong GW, Choi KC, et al. Reference values for serum levels of insulin-like growth factor (IGF-I) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescents. Clin Biochem. 2007;40:1093-1099.
40. Jackson LV, Thalange NK, Cole TJ. Blood pressure centiles for Great Britain. Arch Dis Child. 2007;92:298-303.
41. Fredriks AM, van Buuren S, van Heel WJ, Dijkman-Neerincx RH, Verloove-Vanhorick SP, Wit JM. Nationwide age references for sitting height, leg length, a nd sitting height/height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child. 2005;90:807-812.